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ABSTRACT
Methods: Roots were extracted by successive solvent methods by petroleum ether, chloroform, methanol, butanol, and finally, water. Chloroform 
extract was selected for isolation, and plumbagin was isolated by hexane and ethyl acetate as solvent system. Plumbagin was evaluated by Morris 
water test, and brain acetylcholine esterase level was measured.
Result: Plumbagin showed a significant decrease of escape latency and increase of time spent in target quadrant by mice in Morris water maze 
indicating improvement of learning and memory. It also significantly decreases the cholinesterase level in the brain.
Conclusion: Learning and memory of mice doubtless may be through embarrassment of brain acetyl cholinesterase activity and through involvement of 
GABA-benzodiazepine pathway. Further detailed study is required to explore the other possible mechanisms for the management of cognitive disorders.
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INTRODUCTION
Alzheimer’s disease is a progressive neurodegenerative disorder 
characterized by the gradual commencement of dementia. It is 
characterized by gradually progressive refuse in cognitive function, 
with deficits, especially in memory recovery [1]. A number of 
cholinesterase inhibitors are in clinical practice for the management 
of various cognitive disorders [2]. However, they are associated with 
a number of adverse effects, i.e., anorexia, nausea, vomiting, diarrhea, 
and insomnia [3]. Hence, there has been intense attention focused on 
the part of potential phytochemical to modulate neuronal function 
and protective mechanism against degeneration. As complementary 
and alternative therapy, herbal medicine or phytotherapy refers to the 
medical exploitation of plant components for their curative properties. 
A number of medicinal plants are reported and widely used in Ayurveda 
and other system of medicine for neurodegenerative disorders. Among 
all reported medicinal plants, Plumbago zeylanica (chitraka) is well-
known medicinal plant for neurodegenerative disorders.
P. zeylanica is an old-age Rasayana herb in traditional Ayurveda. 
P. zeylanica Linn. is distributed as a weed throughout the tropical and 
subtropical countries of the world [4] native to South Asia and cultivated 
throughout India and Sri Lanka. It belongs to family Plumbaginaceae [5-
7]. The roots of P. zeylanica are also used as expectorant, antirheumatic, 
anti-scabies, appetite stimulant, anti-diarrheal, antiperiodic, and 
antimalarial and for the treatment of leprosy [4] The second hand of 
whole plant, roots, and powder of the roots [8,9] is in fever and malaria, 
in opposition to diarrhea, dyspepsia, piles, and skin diseases including 
leprotic lesions, learning, and memory [10-12].
In our previous study, various extracts of roots of P. zeylanica were 
evaluated by Morris water test and their brain acetylcholine esterase 
level was measured. Among all the extracts, chloroform extract 
showed potent activity for learning and memory [13]. Phytochemical 
study of chloroform extract showed the presence of active compound, 
i.e., plumbagin. Hence, an attempt was made for the bioactivity-guided 
isolation of active compound from chloroform extract and its evaluation 
in various models of learning and memory.
METHODS
Procurement of plant material
The roots of P. zeylanica were purchased from the market. The roots were 
taxonomically identified and authenticated by senior botanist. A voucher 
specimen is preserved in the department for the further reference.
Successive solvent extraction method
The roots (250 g) were dried in shade and sliced into small pieces and 
pulverized using a mechanical grinder for the coarse powder. The coarse 
powder of root was subjected to Soxhlet extraction using petroleum 
ether to remove all fats. The marc was dried and then extracted by using 
chloroform, methanol, butanol, and finally with water for 72 h. After 
exhaustive extraction, the extracts were filtered, concentrated, and 
dried. All the extracts were screened for the presence of alkaloids, fatty 
acids, terpenoids, steroids, flavonoids, and glycosides. Since chloroform 
extract showed potent activity in Morris water test, it is selected for 
further isolation and characterization of active compounds.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i7.2708
Research Article
Objective: The main aim of our study is to isolate the active compound from roots of Plumbago zeylanica Linn. by bioactivity-guided isolation and 
evaluate its memory-enhancing effect by Morris water maze.
Chromatographic  separation  and  isolation  of  active  compound
Completely dried chloroform extract (25 g) was subjected to 
chromatographic separation by loading of extract on glass column 
(90×3c). For the stationary phase, silica gel was used. Isolation of 
compound was followed by gradient elution method. In this method, 
n-hexane containing increasing amounts of ethyl acetate (90:10, 80:20, 
70:30, 60:40, 50:50, 40:60, and 30:70) was used as the solvent system. 
The column was eluted by n-hexane containing increasing amounts of 
ethyl acetate till 90% of the process completed. One thirty-five fractions 
were together and fractions showing similar chromatogram on thin-
layer  chromatography plate  were pooled together  and total  four  (F1-
F4) fractions were prepared. The percentage yields of fractions were 
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determined. Fractions (F2) eluted showing only one spot on TLC 
(n-hexane:ethyl acetate, 9:1, Rf-0.61) were pooled and evaporated to 
dryness, yielding plumbagin (F2). After isolation of active compound, 
melting point of plumbagin was recorded by capillary tube method. 
For the spectral determination of compound, various spectral methods, 
i.e., ultraviolet and infrared spectra were followed [14].
Experimental animals
Disease-free Swiss male albino mice (25–35 g) were used for this 
experiment, and they were purchased from the Committee for the 
Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA) approved vendor. Animals were housed separately in 
polycarbonate cage in groups of 6–8 per cage under proper laboratory 
conditions with alternating light and dark cycle of 12 h each. Before 
the experiment, the protocol was approved by the Institutional Animal 
Ethics Committee and animal care was in use as per the strategy of 
CPCSEA, Ministry of Environment and Forests, Government of India.
Morris water maze
The method and parameters for learning and memory of mice using 
Morris water maze were followed as reported earlier [15-17].
Animals were divided in eight groups and six animals were placed in 
each group. Group 1 served as control and Group 2 as standard drug 
(physostigmine, 0.1 mg/kg i.p.) treated. Animals of Groups 3 and 4 were 
treated by plumbagin in a dose of 1.5 and 3 mg/kg, rats of Groups 5 and 6 
were treated by scopolamine and diazepam in a dose of 0.4 and 1 mg/kg, 
and rats of Groups 7 and 8 were treated by plumbagin and combination 
of scopolamine and diazepam, respectively, were administered for 
15 consecutive days. Escape latency (EL) was recorded 120 min after 
drug administration from 11th day to 14th day. On the 15th day, time 
spent in target quadrant (TSTQ) was noted 120 min following the drug 
administration. In case of animals administered with physostigmine, EL 
and TSTQ were noted after 30 min of drug administration.
Measurement of locomotor activity
All the eight groups were treated by drugs, respectively, which were 
administered for 15 successive days. Locomotor activity was measured 
on the 15th day using actophotometer (INCO, Ambala).
Biochemical estimation
Collection of brain sample
After the 15th day using Morris water maze, the animals were sacrificed 
on the 16th day by cervical dislocation. Whole brain was carefully 
removed from the animals. The fresh whole brain was weighed first and 
then homogenized in 10 volumes of 0.1 M phosphate buffer (pH 8) using 
a glass homogenizer. The homogenate was centrifuged at 3000 rpm 
for 10 min at 4°C using refrigerated centrifuge (Remi, Mumbai). The 
resultant cloudy supernatant liquid was used for the estimation of brain 
acetylcholinesterase activity [18].
Estimation of acetylcholinesterase activity
0.4 ml of brain homogenate was placed into a test tube containing 
2.6 ml of phosphate buffer. 5, 5-dithiobis-2-nitrobenzoic acid reagent 
(0.1 ml) was added to the above mixture, and absorbance was noted at 
412 nm. Then, 0.02 ml of acetylcholine iodide solution was added and 
again absorbance was noted 15 min thereafter. Change in absorbance 
per minute was calculated [18].
Statistical analysis
Data were analyzed by analysis of variance followed by Tukey’s post hoc 
test in GraphPad prism. p<0.05 was considered as statistically significant. 
All the results are expressed as mean±standard error of the mean.
RESULTS
Effect of plumbagin on EL and time spent in target quadrant TSTQ
EL and time spent in target quadrant are associated with learning and 
memory, and decrease of EL and increase of TSTQ by mice in Morris 
water maze indicate an improvement of learning and memory. In our 
study, plumbagin (1.5 and 3 mg/kg) and physostigmine (0.1 mg/kg, 
i. p.) administered for 15 successive days. After administration, they 
significantly decreased EL of mice from 11th to 14th day and augmented 
TSTQ by mice on the 15th day as compared to the control, thus showing 
learning and memory enhancement effect. Rats treated by plumbagin in 
a dose of 3 mg/kg significantly upturned scopolamine- and diazepam-
induced amnesia as compared to scopolamine- and diazepam-treated 
groups (Figs. 1 and 2).
Effect of plumbagin on locomotor activity of mice
There was a significant change in locomotor activity in mice treated 
by plumbagin (1.5 and 3 mg/kg) and physostigmine as compared to 
vehicle-treated control (Fig. 3).
Effect of plumbagin on brain acetylcholine esterase activity of mice
Animals treated by plumbagin and physostigmine for 15 successive 
days produced a significant reduction in brain acetylcholinesterase 
activity as compared to control group. Mice treated by plumbagin in a 
dose of 3 mg/kg showed a highly significant decreasing effect on brain 
acetylcholinesterase activity compared to rats of control group. Results 
were expressed in Fig. 4.
DISCUSSION
Herbs have been employed from 1000 of years, in several forms, 
under the indigenous system of medicine such as Ayurveda, Unani, 
and Siddha. The unbelievable development in the ground of synthetic 
drugs during present era is accompanied by numerous unwanted side 
effects, whereas plants still grasp their own unique position, with lesser 
Fig. 1: Effect of plumbagin on escape latency (s) on different days. 
Values are expressed as mean±standard error of the mean, n=6 
in each group; *p<0.05, compared to disease control ** p<0.01, 
compared to disease control. ***p<0.001, compared to disease 
control
Fig. 2: Effect of plumbagin on TQ on the 15th day. Values are 
expressed as mean±standard error of the mean, n=6 in each 
group; *p<0.05, compared to disease control **p<0.01, compared 
to disease control. ***p<0.001, compared to disease control
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side effects and more safety [19-21]. In our present investigation, 
bioactivity-guided isolation was followed for the isolation of plumbagin 
and it was administered for 15 successive days. Morris water test was 
employed as a behavioral model for the evaluation of learning and 
memory and plumbagin considerably improved learning and memory 
of mice in relevant test.
In our study, we have selected scopolamine and diazepam since they are 
reported for the impairment of memory in experimental animals [22]. 
In our investigation, mice treated by plumbagin (1.5 and 3 mg/kg, p.o.) 
administered for 15 successive days significantly overturned amnesia 
induced by scopolamine and diazepam in mice. By the creation of 
benzodiazepine receptors and GABAergic system, benzodiazepines 
produce amnesia in animals [18]. Benzodiazepine-receptor antagonist, 
i.e., flumazenil has been reported to invalidate benzodiazepine-induced 
amnesia [23]. Facilitation of cholinergic transmission and inhibition 
of GABA-benzodiazepine pathway may be probable mechanism of 
plumbagin in scopolamine- and diazepam-induced amnesia.
that the memory-enhancing consequence of plumbagin due to inhibition 
of acetylcholinesterase leads to increase in brain acetylcholine levels. 
Thus, the drugs which improve cholinergic function can be used for the 
treatment of dementia closely connected to Alzheimer’s disease.
CONCLUSION
By this study, it can be concluded that roots of P. zeylanica prove its claim 
for memory-enhancing effect according to Ayurveda and other system 
of medicine. Plumbagin was isolated as chief active phytoconstituents 
by bioactivity-guided isolation and it significantly improved learning 
and memory of mice doubtless through embarrassment of brain 
acetylcholinesterase activity and through involvement of GABA-
benzodiazepine pathway. Further detailed study is required to explore 
the other possible mechanisms for the management of cognitive 
disorders.
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